Here, Dr Neil Polwart, Novarum founder and BBI group head of mobile, goes into greater detail about how digital technologies will herald a new era for pharma.
According to new research from global professional services company, Accenture, there is an estimated £22 billion that could be unlocked by pharmaceutical companies over the next 10 years through harnessing digital technologies.
All signs are that the life sciences and healthcare market is ripe for disruption, with ecommerce coming into its own in the sector. Scott Allison, president Life Sciences & Healthcare, DHL, lists five reasons as to why it is happening now.
In the first of the Tech Talk series, Novarum founder and BBI group head of mobile, Dr Neil Polwart, goes through his seven key tips that should be kept at front of mind when trying to implement a successful mHealth strategy.
As people search for healthcare information online more frequently and the digital market keeps growing the boundary between offline & online is becoming more blurred for pharma. Jake Holyoak from Mediaworks details the key challenges & opportunities
In this article, François Feig, head of Global General Medicine and Endocrinology, Merck, explores technological advancements in healthcare and how they can be used to improve patients’ lives.
Digital health is a major trend topic in pharma with many companies investing in the field and looking at ways the tech can be utilised. In this Q&A, Norbert Haberland speaks about how Datwyler is taking on the challenges of this advancing field
Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space?
Incorporating telehealth solutions into new drug delivery technologies like nanomedicines can potentially give pharmaceuticals the edge they need to win the fight against disease, says Alexander Myskiw, healthcare & life sciences practice, DataArt
A new study from Best Practices has revealed that even though the uptake in tablet technology has increased in popularity for field-based medical roles, such as MSLs, this has not necessarily translated into improved effectiveness.
